Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 68462-565

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68462-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Chart titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' showing effect estimates from various studies comparing breast cancer risk between combined oral contraceptive (COC) users versus non-users. Studies include NICHD Women’s Care, French E3N cohort, Shanghai Women’s Health, Nurses' Health Study II, Oxford Family Planning, and Danish Sex Hormone Register. The horizontal axis represents effect estimate values ranging from -1.50 to 2.00. Data points with confidence intervals illustrate odds ratios (OR), relative risks (RR), and hazard ratios (HR).*

FDA Label Image

Chemstructures (Chemstructures)

Chemical structure of Norgestimate, USP, and Ethinyl Estradiol, USP, shown as two separate molecular diagrams. Each structure illustrates the arrangement of atoms and functional groups specific to these active ingredients in the combination drug Norgestimate and Ethinyl Estradiol.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Img3 (Img3)

A chart illustrating pregnancy rates per 100 women in one year relative to different birth control methods. The chart is vertically oriented with 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom. Methods are categorized by effectiveness: implants, injections, intrauterine devices, and sterilization show the fewest pregnancies; birth control pills, skin patch, and vaginal ring with hormones follow; condoms and diaphragm are listed next; no sex during fertile days, spermicide, and withdrawal have higher pregnancies; and no birth control is associated with the most pregnancies.*

FDA Label Image

Figurea (Figurea)

Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg packaged in a 28-day oral tablet calendar kit. The kit includes 21 blue active pills and 7 light green inactive pills, arranged in four weekly rows, with days of the week labeled to guide dosing. The labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Figureb (Figureb)

An illustrated pill pack chart for Norgestimate and Ethinyl Estradiol tablets, showing a 4-week cycle segmented by day of the week (Sunday to Saturday) and week (1 to 4). It indicates four pill types by color: white to off-white, light blue, and blue pills are active, while light green pills are inactive. A caution note about child resistance is included.*

FDA Label Image

Figurec (Figurec)

An instructional diagram showing a finger peeling a circular tablet from a blister pack. The diagram includes arrows labeled "Start" and "Week 2," pointing to tablets under the day labels "SUN" and "MON." This figure (Figure C) illustrates how to remove tablets according to days of the week during usage.*

FDA Label Image

Figured (Figured)

Instructional illustrations showing how to use blister cards for Norgestimate and Ethinyl Estradiol tablets. Two separate 28-day pill packs are depicted, each marked with days of the week and weeks 1 through 4. A hand is shown peeling back a foil strip to access a tablet, demonstrating the daily oral contraceptive regimen.*

FDA Label Image

Figuree (Figuree)

An instructional line drawing labeled 'Figure E' showing a hand placing a tablet onto a circular daily pill slot in a medication kit. The diagram highlights the 'Start' and 'Week 2' rows beneath days of the week columns, including Sunday and Monday, indicating a dosing schedule for Norgestimate and Ethinyl Estradiol kit.*

FDA Label Image

Figuref (Figuref)

An instructional diagram showing a calendar layout for a weekly pill schedule from Sunday to Monday across four weeks, labeled Start, Week 2, Week 3, and Week 4. The image includes an illustration of a hand holding a pill blister, demonstrating pill removal from the packaging, related to the Norgestimate and Ethinyl Estradiol kit.*

FDA Label Image

Cartonlabel2 (Cartonlabel2)

Flat packaging label for Norgestimate and Ethinyl Estradiol Tablets, USP kit by Glenmark Pharmaceuticals Inc., USA. The label features the product name, strength 0.25 mg/0.035 mg, and specifies a 28-day regimen with 3 blister cards each containing 28 tablets. It includes usual dosage and storage instructions along with barcodes and contact information.*

FDA Label Image

Cartonlabel1 (Cartonlabel1)

Norgestimate and Ethinyl Estradiol Tablets USP kit packaging label by Glenmark Pharmaceuticals Inc., USA. The label highlights three strengths: 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg. It includes a 28-day regimen with 3 blister cards totaling 28 tablets. The packaging features dosage instructions, storage conditions, and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.